- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/54 - Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 213/54
Total number of patents in this class: 59
10-year publication summary
|
2
|
1
|
1
|
6
|
4
|
3
|
6
|
4
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Fortephest Ltd. | 9 |
4 |
| Abbvie Inc. | 1800 |
3 |
| Shenzhen Chipscreen Biosciences Ltd. | 25 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 875 |
3 |
| Toyama Chemical Co., Ltd. | 102 |
3 |
| VALO Health, Inc. | 172 |
3 |
| The Regents of the University of California | 19961 |
2 |
| Genentech, Inc. | 3976 |
2 |
| Bayer Pharma AG | 1053 |
2 |
| Epizyme, Inc. | 373 |
2 |
| Nippon Shinyaku Co., Ltd. | 322 |
2 |
| Calico Life Sciences LLC | 96 |
2 |
| Glaxo Group Limited | 4063 |
1 |
| Bristol-myers Squibb Company | 4880 |
1 |
| Boehringer Ingelheim International GmbH | 4642 |
1 |
| Syngenta Crop Protection AG | 6074 |
1 |
| Syngenta Limited | 454 |
1 |
| DSM IP Assets B.V. | 5585 |
1 |
| CHDI Foundation, Inc. | 106 |
1 |
| DAC S.r.l. | 11 |
1 |
| Other owners | 20 |